Clinical Impact of New Rheumatoid Arthritis Findings From ACR/ARP 2020 *

November 5-9, 2020; Virtual Meeting
Review the latest RA management data with Capsule Summaries and expert-authored commentaries covering key studies from ACR/ARP 2020.

Share

Program Content

10 Capsule Summary Slidesets

Activities

HZ/su Vaccine With JAKs
Immunogenicity of Adjuvanted Herpes Zoster Subunit Vaccine in Patients With RA Treated With JAK Inhibitors vs Controls
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2020

Expires: November 08, 2021

HCQ Cardiotoxicity in RA
Lack of Association Between Hydroxychloroquine and Cardiac Events in Patients With RA
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

MTX Machine Learning
Use of a Pharmacogenomics-Driven Machine Learning Approach to Predict Patient Response to Methotrexate
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

ARCTIC REWIND: TNFi Taper
ARCTIC REWIND: Tapering and Withdrawing TNF Inhibitor Associated With Higher Flare Risk in Patients With RA in Stable Remission
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2020

Expires: November 12, 2021

SELECT VTE Analysis
SELECT Pooled Analysis: Incidence and Risk Factors for VTE in Patients With RA Treated With Upadacitinib
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2020

Expires: November 08, 2021

Filgotinib VTE/MACE Analysis
Pooled Analysis of Filgotinib Trials in RA: Incidence and Risk Factors for VTE and MACE
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2020

Expires: November 12, 2021

Dutch Arthralgia Cohorts
In Multicohort Dutch Study, Most Arthralgia Patients With Subclinical Synovitis Did Not Progress to Inflammatory Arthritis After 3 Yrs
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2020

Expires: November 09, 2021

MD- vs PT-CDAI in Telemedicine
CATCH/CATCH-US Pooled Analysis: Comparison Between Clinician-Assessed vs Patient-Reported CDAI in Patients With Early RA in Telemedicine
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2020

Expires: November 08, 2021

SEAM-RA
SEAM-RA: Maintenance of Remission Better After Withdrawal of Methotrexate Than Withdrawal of Etanercept
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Expires: November 11, 2021

Sarilumab ± MTX
MONARCH vs MOBILITY: Similar Efficacy With Sarilumab ± MTX in MTX-IR/INT RA
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Activities

RA Insights From IL-6 Inhibitors
ACR/ARP 2020: New Data on Optimizing Use of IL-6 Inhibitors
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

RA Tapering
ACR/ARP 2020: New Data on Tapering RA Medications During Remission
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2020

Expires: December 17, 2021

RA Safety Updates
ACR/ARP 2020: Herpes Zoster Vaccine and New Safety Data on RA Therapeutics
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2020

Expires: December 17, 2021

Evaluating RA in 2020
Evaluating RA in 2020
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2020

Expires: December 17, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Sanofi Genzyme Corp

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.